A national strategy for the elimination of hepatitis B and C : phase two report / Gillian J. Buckly and Brian L. Stom, editors ; Committee on a National Stategy for the Elimination of Hepatitis B and C, Board of Population Health and Public Health Practice, Health and Medicine Divsion ; a report of the National Academies of Sciences, Engineering, Medicine.

Format:

Book

Contributor:

Buckly, Gillian J., editor.

Stom, Brian L., editor.

Committee on a National Stategy for the Elimination of Hepatitis B and C.

Board of Population Health and Public Health Practice.

Health and Medicine Divsion.

National Academies of Sciences, Engineering, Medicine.

Language:

English

Subjects (All):

Hepatitis B--United States--Prevention.

Hepatitis B.

Hepatitis C--United States--Prevention.

Hepatitis C.

United States.

Physical Description:

1 online resource (297 pages)

Place of Publication:

Washington, District of Columbia : The National Academies Press, 2017.

Summary:

"Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them"-- Publisher's description.

Contents:

Introduction

Targets for elimination

Public health information

Essential interventions

Service delivery

Financing elimination

Research

Appendix A: Population health impact and cost-effectiveness of chronic hepatitis B diagnosis, care, and treatment in the United States

Appendix B: Modeling the elimination of hepatitis C in the United States

Appendix C: Public meeting agenda

Appendix D: Committee biographies.

Notes:

Includes bibliographical references.

Description based on online resource; title from PDF title page (ebrary, viewed August 7, 2017).

ISBN:

9780309457323

0309457327

9780309457309

0309457300